Trial intelligence / Profile preview

CVI and BIS responses to standardized painful stimuli during propofol-remifentanil anesthesia

NL-OMON33289Active, not recruiting

Sponsor
University Medical Center Groningen
Start
Jul 2009
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of propofol and remifentanil, sponsored by University Medical Center Groningen. Primary endpoints: Change in BIS after standardized pain stimulus, Change in CVI after standardized pain stimulus and 1 more. Started Jul 2009; status: active, not recruiting.

02

Drugs

propofolremifentanil

Beyond the preview

Go deeper on NL-OMON33289.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON33289.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call